IP Library Patent Application 18555567
Patent Application
App. No. 18/555,567

EASY CHEW FORMULATIONS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/555,567
Abstract

A composition comprising an edible oil comprising coconut oil, palm kernel oil, palm oil, sunflower oil, hemp seed oil or any combination thereof; an edible triglyceride comprising cocoa butter, mango butter, ghee, hydrogenated palm oil, or any combination thereof; a humectant comprising glycerin, polyethylene glycol, propylene glycol, sorbitol, xylitol, maltitol, or any combination thereof; a binder comprising maltodextrin, sucrose, microcrystalline cellulose, pregelatinized starch, dextrose, lactose, or any combination thereof; and one or more flow aids.

Claims (43)

1 . A composition comprising:

an edible oil comprising coconut oil, palm kernel oil, palm oil, sunflower oil, hemp seed oil or any combination thereof;

an edible triglyceride comprising cocoa butter, mango butter, ghee, hydrogenated palm oil, or any combination thereof;

a humectant comprising glycerin, polyethylene glycol, propylene glycol, sorbitol, xylitol, maltitol, or any combination thereof; and

a binder comprising maltodextrin, sucrose, microcrystalline cellulose, pregelatinized starch, dextrose, lactose, or any combination thereof.

2 . The composition of claim 1 comprising 0.01-16 wt. % edible oil.

3 . The composition of claim 1 comprising 0.01-30 wt. % edible triglyceride.

4 . The composition of claim 1 comprising 2-15 wt. % humectant.

5 . The composition of claim 4 comprising 0.01-7 wt. % polyethylene glycol.

6 . The composition of claim 5 , wherein the polyethylene glycol is PEG-400 to PEG-5000.

7 . The composition of claim 1 comprising 20-70 wt. % of binder.

8 . (canceled)

9 . The composition of claim 1 further comprising one or more active pharmaceutical ingredients.

10 . The composition of claim 9 , wherein the active pharmaceutical ingredient comprises a pain or inflammation reducer, an antihistamine, a decongestant, a cough suppressant, a vitamin, a mineral, a biological active, a sleep aid, a stress-reducing aid, an energy and cognition aid, an Ayurveda supplement, an immunity supplement, a digestive aid, a joint supplement, a cannabinoid, a systemic natural, a nutritional agent, pharmaceutically acceptable salts thereof, or combinations thereof.

11 . The composition of claim 10 , wherein the pain or inflammation reducer comprises ibuprofen, naproxen, acetaminophen, salicylic acid, acetylsalicylic acid, ketoprofen, dexibuprofen, fenoprofen, dexketoprofen, flurbiprofen, oxaprozin, loxoprofen, diflunisal, etodolac, indomethacin, ketorolac, oxaprozin, piroxicam, salsalate, salicylic acid, indomethacin, tolmetin, sulindac, etodolac, ketordolac, diclofenac, aceclofenac, bromfenac, pharmaceutically acceptable salts thereof, or combinations thereof.

12 . The composition of claim 10 , wherein the antihistamine comprises cetirizine hydrochloride, levocetirizine hydrochloride, loratadine, desloratadine, fexofenadine hydrochloride, azelastine hydrochloride, olopatadine hydrochloride, brompheniramine maleate, chlorcyclizine hydrochloride, chlorpheniramine maleate, dexbrompheniramine maleate, dexchlorpheniramine maleate, diphenhydramine citrate, diphenhydramine hydrochloride, doxylamine succinate, phenindamine tartrate, pheniramine maleate, pyrilamine maleate, thonzylamine hydrochloride, triprolidine hydrochloride, pharmaceutically acceptable salts thereof, or combinations thereof.

13 . The composition of claim 10 , wherein the decongestant or cough suppressant comprises phenylephrine hydrochloride, pseudoephedrine hydrochloride, pseudoephedrine sulfate, phenylephrine bitartrate, dextromethorphan, pholcodine, codeine, benzonatate, pharmaceutically acceptable salts thereof, or combinations thereof.

14 . The composition of claim 10 , wherein the vitamin, mineral, or biological active comprises vitamin A, vitamin B, vitamin C, vitamin D, vitamin E, vitamin K, thiamin, riboflavin, niacin, folate, biotin, panthothenic acid, iron, phosphorus, iodine, copper, chromium, molybdenum, chloride, sodium, magnesium, calcium, zinc, selenium, manganese, potassium, choline, lycopene, lutein, L-threanine, coenzyme Q-10, phytosterols, hyaluronic acid, cognizing citicoline, silicon, icotinamide, Andrographis, pharmaceutically acceptable salts thereof, or combinations thereof.

15 . The composition of claim 10 , wherein the sleep aid comprises melatonin, lemon balm, lavender, chamomile, sage, valerian root extract, hops, passionflower extract, or combinations thereof.

16 . The composition of claim 10 , wherein the stress-reducing aid comprising sage, Ashwagandha (Withania somnifera), St. John's Wort, GABA (gamma-Aminobutyric acid), or combinations thereof.

17 . The composition of claim 10 , wherein the energy and cognition aid comprising green tea, ginseng , caffeine, rhodiola extract, B-vitamins, L-theanine, taurine, pharmaceutically acceptable salts thereof, or combinations thereof.

18 . The composition of claim 10 , wherein the Ayurveda supplement comprises amla (Emblica officinalis ), bibhitaki (Terminalia bellirica), haritaki (Terminalia chebula)), Brahmi, cumin, licorice root, Gotu kolay, Cardamom, or combinations thereof.

19 . The composition of claim 10 , wherein the immunity supplement comprises copper, silver, spirulina , astragulus, beta glucan, aceola cherry extract, blood orange extract, elderberry, mushrooms (Lions Mane, Reishi, Shiitake, Cordyceps ), pharmaceutically acceptable salts thereof, or any combinations thereof.

20 . The composition of claim 10 , wherein the digestive aid comprises a probiotic and combinations thereof; digestive enzymes; soluble fibers including psyllium husk, inulin, fenugreek fiber, wheat dextrin; Cascara sagrada; aloe ferox leaves extract, slippery elm bark extract, or combinations thereof.

21 . The composition of claim 10 , wherein the joint supplement comprises collagen, glucosamine, turmeric, methylsulfonylmethane (MSM), pharmaceutically acceptable salts thereof, or combinations thereof.

22 . The composition of claim 10 , wherein the cannabinoid comprises cannabidiol, cannabigerol, pharmaceutically acceptable salts thereof, and combinations thereof.

23 . The composition of claim 10 , wherein the systemic natural comprises one or more of Boswellia, curcumin, devils claw, ginger, feverfew, bromelain, turmeric, and butterbur.

24 . The composition of claim 10 , wherein the nutritional agent comprises black pepper, glycine, valerian root, eucalyptus , menthol, astragalus , bromelain, echinacea , white willow, ivy leaf ( Hedera helix ), ginger ( Zingiber officinale ), pharmaceutically acceptable salts thereof, or combinations thereof.

25 . The composition of claim 1 further comprising a solubility enhancer, a controlled release ingredient, a stabilizer, a taste masking ingredient, an antioxidant, a colorant, a plasticizer, a flavorant, a flow aid, or any combination thereof.

26 . (canceled)

27 . The composition of claim 25 , wherein the flow aid comprises magnesium stearate, colloidal silicon dioxide, calcium stearate, stearic acid, glyceryl monostearate, glyceryl tribehenate, tricalcium phosphate, or any combination thereof.

28 . The composition of claim 27 comprising up to 3 wt. % of one or more flow aids.

29 . The composition of claim 1 , wherein the composition is a tablet.

30 . The composition of claim 29 , wherein the tablet has a hardness of less than 2 kp when tested with a conventional tablet hardness tester and a friability of less than 1.0% at 100 rotations.

31 . A composition comprising a tablet comprising:

0.01-16 wt. % hydrogenated coconut oil;

0.01-14 wt. % cocoa butter,

2-15 wt. % glycerin;

0.01-7 wt. % polyethylene glycol;

20-70 wt. % maltodextrin and sucrose; and

0.1-3 wt. % flow aids,

wherein the tablet has a hardness of less than 2 kp and a friability of less than 1.0% at 100 rotations.

32 - 36 . (canceled)

Assignments (2)
CHANGE OF NAME Recorded Jan 18, 2024
From: GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC
To: HALEON US HOLDINGS LLC
Reel/Frame 066344/0609 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2023
From: DESAI, NIKITA SANDEEP; ENGLAND, KENNETH EARL; PATEL, SHIVANGI AKASH; PHAM, THANH VAN NGUYEN
To: GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC
Reel/Frame 065227/0321 →